MyopiaNCT01839318
Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses
A study testing Nelfilcon A contact lenses, Omafilcon A contact lenses and Etafilcon A contact lenses in people with Myopia and Hyperopia, run by Alcon Research.
Trial summary
The purpose of this study was to compare three CE-marked daily disposable contact lenses for tear film stability as measured by pre-lens non-invasive keratograph break up time (PL NIK-BUT). Secondarily, contact lens surface wettability was assessed. Read more about this study
- Who is it for?
- Ages 18 to 44 years
- Conditions the study is for
- Myopia, Hyperopia, Refractive Error
- What is being tested?
- Nelfilcon A contact lenses, Omafilcon A contact lenses and Etafilcon A contact lenses
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- Apr 2013to Jun 2013
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 44 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Sign Informed Consent.
- Adapted soft contact lens wearer.
- Willing to wear contact lenses up to 12 hours and attend all study visits.
- Vision correctable to 0.1 (logMAR) or better in each eye at distance with pre-study lenses at Visit 1.
- Contact lens prescription within the power range specified in the protocol.
- Other protocol-defined inclusion criteria may apply.
Who cannot join
- Any ocular infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
- Any use of systemic or ocular medications that would contraindicate contact lens wear.
- Any ocular finding observed during the Visit 1 examination that would contraindicate contact lens wear.
- Monocular (only 1 eye with functional vision) or fit with only 1 lens.
- History of herpetic keratitis, ocular surgery, or irregular cornea.
- Known pregnancy.
Show all 9Show fewer
- Unstable tear film with a NIK-BUT value below 13 seconds in either eye without lenses.
- Participation in any clinical study within 30 days of Visit 1.
- Other protocol-defined exclusion criteria may apply.
About this study
Official title: Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection
The purpose of this study was to compare three CE-marked daily disposable contact lenses for tear film stability as measured by pre-lens non-invasive keratograph break up time (PL NIK-BUT). Secondarily, contact lens surface wettability was assessed.
Read the detailed description
Each participant wore 3 brands of contact lenses in a randomized, cross-over fashion, with a washout phase of at least 1 night between brands.
- Conditions
- Myopia, Hyperopia, Refractive Error
- Being tested
- Nelfilcon A contact lenses, Omafilcon A contact lenses, Etafilcon A contact lenses
- Keywords
- Soft contact lenses, Daily disposable contact lenses, Tear Film Break Up Time, Contact lens wettability
- Medical subject headings
- Myopia, Hyperopia, Refractive Errors
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nelfilcon A contact lensesDevice
Also called DAILIES® AquaComfort Plus®
Omafilcon A contact lensesDevice
Also called Proclear® 1 day
Etafilcon A contact lensesDevice
Also called 1-DAY ACUVUE® MOIST®
| Study group | Role | What they receive |
|---|---|---|
| DAILIES AquaComfort Plus | Experimental | Nelfilcon A contact lenses worn first, followed by etafilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours. Receives: Device: Nelfilcon A contact lenses |
| 1-DAY ACUVUE MOIST | Active comparator | Etafilcon A contact lenses worn first, followed by nelfilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours. Receives: Device: Etafilcon A contact lenses |
| Proclear 1 day | Active comparator | Omafilcon A contact lenses worn first, followed by etafilcon A and nelfilcon A in randomized order. Each product worn for 1 day, 12 hours. Receives: Device: Omafilcon A contact lenses |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours
The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the contact lens using an Oculus Keratograph 5 and the tear film reflection was observed. PL NIK-BUT was recorded at the first sign of distortion. A longer tear film break-up time indicates a more stable tear film. One eye (right eye) contributed to the mean.
Measured: Hour 8
Secondary outcomes (1)
Total Wettability Score
The investigator graded lens wettability by corneal region using a scale from 0 (fully wettable) to 3 (clearly visible ring distortions in more than 1/3 of ring reflection zone). The total wettability score per eye was calculated by averaging the grade of each of the 5 corneal regions (central, superior, nasal, inferior, and temporal). One eye (right eye) contributed to the mean.
Measured: Hour 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2013 (estimated)
- Study startApr 2013
- Primary completionJun 2013
- Study completionJun 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for MyopiaStudies of the same condition, open and under way.
- More trials run by Alcon ResearchThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alcon Research
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Jessie Lemp, PhD, Study director, Alcon Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01839318
- Sponsor's protocol ID
- A01336
- Status last verified
- May 2014
- First submitted
- 22 Apr 2013
- Last updated
- 20 Jun 2014
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jun 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection
- ClinicalTrials.gov ID
- NCT01839318
- Acronym / sponsor ID
- A01336
- Conditions
- Myopia, Hyperopia, Refractive Error
- Keywords
- Soft contact lenses, Daily disposable contact lenses, Tear Film Break Up Time, Contact lens wettability
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Alcon ResearchIndustry (pharma, biotech, devices)
- Study start
- Apr 2013
- Primary completion
- Jun 2013 (actual)
- Study completion
- Jun 2013 (actual)
- First posted
- 24 Apr 2013 (estimated)
- Results
- Posted 20 Jun 2014
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to compare three CE-marked daily disposable contact lenses for tear film stability as measured by pre-lens non-invasive keratograph break up time (PL NIK-BUT). Secondarily, contact lens surface wettability was assessed.
Detailed description
Each participant wore 3 brands of contact lenses in a randomized, cross-over fashion, with a washout phase of at least 1 night between brands.
Study design
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| DAILIES AquaComfort Plus | Experimental | Device: Nelfilcon A contact lensesNelfilcon A contact lenses worn first, followed by etafilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours. |
| 1-DAY ACUVUE MOIST | Active comparator | Device: Etafilcon A contact lensesEtafilcon A contact lenses worn first, followed by nelfilcon A and omafilcon A in randomized order. Each product worn for 1 day, 12 hours. |
| Proclear 1 day | Active comparator | Device: Omafilcon A contact lensesOmafilcon A contact lenses worn first, followed by etafilcon A and nelfilcon A in randomized order. Each product worn for 1 day, 12 hours. |
Who may qualify
- Ages
- 18 to 44 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Sign Informed Consent.
- Adapted soft contact lens wearer.
- Willing to wear contact lenses up to 12 hours and attend all study visits.
- Vision correctable to 0.1 (logMAR) or better in each eye at distance with pre-study lenses at Visit 1.
- Contact lens prescription within the power range specified in the protocol.
Key exclusion criteria (9 listed)
- Any ocular infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
- Any use of systemic or ocular medications that would contraindicate contact lens wear.
- Any ocular finding observed during the Visit 1 examination that would contraindicate contact lens wear.
- Monocular (only 1 eye with functional vision) or fit with only 1 lens.
- History of herpetic keratitis, ocular surgery, or irregular cornea.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Nelfilcon A contact lensesAlso: DAILIES® AquaComfort Plus® | Device | DAILIES AquaComfort Plus |
| Omafilcon A contact lensesAlso: Proclear® 1 day | Device | Proclear 1 day |
| Etafilcon A contact lensesAlso: 1-DAY ACUVUE® MOIST® | Device | 1-DAY ACUVUE MOIST |
Primary outcome
Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours
Time frame: Hour 8
The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the contact lens using an Oculus Keratograph 5 and the tear film reflection was observed. PL NIK-BUT was recorded at the first sign of distortion. A longer tear film break-up time indicates a more stable tear film. One eye (right eye) contributed to the mean.
1 secondary outcome
Total Wettability Score
Time frame: Hour 8
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jun 2014.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Myopia
Recruiting
Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
Pre-myopia, Myopia
Not yet recruiting
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment
Myopia, Myopia Progressing
Not yet recruiting
Clinical Performance and Outcomes After Toric Lens Transition
Astigmatism
Active, not recruiting
Effect of IOP Lowering on Progressive HM
High Myopia, Intraocular Pressure
Recruiting
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Hyperopia and Myopia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jessie Lemp, PhD study director
Alcon Research
Questions about this trial
What is this clinical trial studying?
A study testing Nelfilcon A contact lenses, Omafilcon A contact lenses and Etafilcon A contact lenses in people with Myopia and Hyperopia, run by Alcon Research.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 20 Jun 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pre-Lens Non-Invasive Keratograph Break Up Time (PL NIK-BUT) at 8 Hours (time frame: Hour 8). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jun 2014.